For adults with attention-deficit/hyperactivity disorder (ADHD) who also have children with ADHD, pairing a stimulant medication with a parenting intervention can lead to significant reductions in their child’s ADHD severity. The
findings were published in the
Journal of Child Psychology and Psychiatry.
Why It’s Relevant
Because ADHD interferes with executive functioning and emotion regulation, parents with the disorder may have difficulty implementing evidence-based parenting strategies to manage their children. Though previous research suggests that treating parental ADHD alone doesn’t meaningfully improve child outcomes, few studies have investigated the impact of pairing pharmacological treatments with integrated behavioral parent training (I-BPT), which combines parent training with cognitive-behavioral strategies targeting parental ADHD.
By the Numbers
- Researchers divided 120 parent/child pairs (75% mothers; 66% male children; mean child age of 6) to receive either I-BPT or I-BPT plus parent stimulant medication (starting at 20mg and increasing to 60mg as needed). The children did not receive stimulants.
- Child ADHD severity improved for both groups, but children whose parents received medications experienced a greater and more rapid reduction. Child Clinical Global Impressions-Severity (CGI-S) scale scores fell from an average of 4.52 to 3.67 after nine months in the plus-medication group, compared with 4.31 to 3.96 among the children whose parents received I-BTP alone.
- Parents who received stimulants also showed faster reductions in their own CGI-S scores, which fell from 3.52 to 2.96 after nine months, compared with 4.24 to 3.98 in the I-BPT-only group.
- Further, parents who received stimulants also reported greater improvements in positive parenting (praising their children and positive touch) and less inconsistent discipline.
The Other Side
Families in the study were overall socioeconomically advantaged, with annual average incomes over $150,000. Accordingly, the findings may not generalize to families who face greater structural barriers to treatment. Further, only parents willing to take medication were assigned to the stimulant arm of the study. Qualitative findings suggest that many families (particularly families of color) expressed medication hesitancy due to historical mistreatment.
Takeaway Message
“When parent ADHD was addressed pharmacologically, children showed faster reductions in clinical severity, parents demonstrated faster reductions in their own clinical severity, and select parenting practices improved beyond behavioral intervention alone,” the researchers wrote. Future studies should focus on strategies that improve access for families experiencing economic disadvantage and other structural barriers to ADHD treatment.
Related Information
Source
Andrea Chronis-Tuscano, et al. Treating parents with ADHD and their children (TPAC): a hybrid effectiveness-implementation, randomized controlled trial. Journal of Child Psychology and Psychiatry. Published online August 18, 2026. doi:10. 10.1111/jcpp.70222
(Image: Getty Images/iStock/kieferpix)